GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Other Operating Expense

Allergy Therapeutics (LSE:AGY) Other Operating Expense : £-1.33 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Other Operating Expense?

Allergy Therapeutics's Other Operating Expense for the six months ended in Dec. 2023 was £-0.76 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was £-1.33 Mil.

Allergy Therapeutics's quarterly Other Operating Expense declined from Dec. 2022 (£-0.28 Mil) to Jun. 2023 (£-0.57 Mil) and declined from Jun. 2023 (£-0.57 Mil) to Dec. 2023 (£-0.76 Mil).

Allergy Therapeutics's annual Other Operating Expense declined from Jun. 2021 (£-0.57 Mil) to Jun. 2022 (£-0.74 Mil) and declined from Jun. 2022 (£-0.74 Mil) to Jun. 2023 (£-0.86 Mil).


Allergy Therapeutics Other Operating Expense Historical Data

The historical data trend for Allergy Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Other Operating Expense Chart

Allergy Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.59 -0.63 -0.57 -0.74 -0.86

Allergy Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.25 -0.49 -0.28 -0.57 -0.76

Allergy Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics (LSE:AGY) Business Description

Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines